Choi et al. [146] detected a resistance mechanism by which miR-622 induced cis- and carboplatin resistance in BRCA1 mutant high-grade serous ovarian carcinomas by targeting the Ku complex and restoring homologous recombination mediated double strand break repair. The gene discussed is BRCA1; the disease is ovarian serous carcinoma.